![PDF) Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: A randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold PDF) Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: A randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold](https://i1.rgstatic.net/publication/45582542_Efficacy_and_safety_of_an_antiviral_Iota-Carrageenan_nasal_spray_A_randomized_double-blind_placebo-controlled_exploratory_study_in_volunteers_with_early_symptoms_of_the_common_cold/links/0912f50b475edc00a9000000/largepreview.png)
PDF) Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: A randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold
![Promising new molecule discovered in Canada shown to block SARS-CoV-2 could be developed as a nasal spray drug for COVID-19 – CoVaRR-Net Promising new molecule discovered in Canada shown to block SARS-CoV-2 could be developed as a nasal spray drug for COVID-19 – CoVaRR-Net](https://covarrnet.ca/wp-content/uploads/2022/03/CoVaRR-Net_icons_antimicrobial-treatments.png)
Promising new molecule discovered in Canada shown to block SARS-CoV-2 could be developed as a nasal spray drug for COVID-19 – CoVaRR-Net
![PDF) Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: A randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold PDF) Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: A randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold](https://www.researchgate.net/profile/Andreas-Grassauer/publication/45582542/figure/fig2/AS:213405110673418@1427891151631/Mean-symptom-scores-over-7-days-Mean-SEM-for-Carrageenan-nasal-spray-black-squares_Q320.jpg)